Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat

Pharmacology, Biochemistry and Behavior

Volumn 29, Issue 1, 1988, Pages 205-208

  Ljungberg, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticholinergics; Consummatory acts; Dopamine; Extrapyramidal side effects; Haloperidol; Operant behaviors; Rats

Indexed keywords

DOPAMINE; HALOPERIDOL; SCOPOLAMINE;

ANIMAL EXPERIMENT; FLUID INTAKE; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; RAT;

ANIMAL; CONDITIONING, OPERANT; DRINKING; HALOPERIDOL; MALE; RATS; RATS, INBRED STRAINS; SCOPOLAMINE; SUPPORT, NON-U.S. GOV'T; WATER;

EID: 0023834868     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(88)90298-5     Document Type: Article

References (31)

1. Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade
2. Differential reversal by scopolamine and THIP of the antistereotypic and cataleptic effects of neuroleptics
3. Differential reversal by scopolamine of effects of neuroleptics in rats. Relevance for evaluation of therapeutic and extrapyramidal side-effect potential
4. Drugs and the treatment of psychiatric disorders
5. The role of dopamine in locomotor activity and learning
6. A comparison of atropine, benzotropine and diphenhydramine on the reversal of haloperidol induced supression and self-stimulation
7. Reversal of haloperidol induced deficits in self-stimulation by anti-parkinsonian drugs
8. Drug-induced extrapyramidal symptoms and their relation to clinical efficacy
9. Decreased antistereotypic effects of neuroleptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound
10. Dopamine and the neural mechanisms of reinforcement
11. Haloperidol-induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs
12. Behavioural actions of neuroleptics
13. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?
14. The interaction of neuroleptic and muscarinic agents with central dopaminergic systems
15. Blockade by neuroleptics of water intake and operant lever pressing for water in the rat: Anhedonia, motor deficit or both?
16. Decision making by rats in an unpredictable laboratory environment: Final decision rules
17. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence of two different mechanisms of action
18. Evidence that the different properties of haloperidol and clozapine are not explained by difference in anticholinergic potencies
19. A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs
20. Effects of antiparkinson drugs on a phenothiazine-induced catatonic reaction
21. Influence of antiparkinson drugs and amphetamine on some pharmacological effects of phenothiazine derivatives used as neuroleptics
22. Neuroleptics Relation between cataleptic and anti-turning actions and role of the cholinergic system
23. Alterations by centrally acting drugs of the suppression of self-stimulation behaviour in the rat by tetrabenazine, physostigmine, chlorpromazine and pentobarbital
24. Pharmacological properties of new antipsychotic agents: Use of animal models
25. Beeinflussung verschiedener Wirkungen von Thiopropazat durch ein zentrales Stimulans
26. Brain dopamine receptors
27. Differential attenuation of some effects of haloperidol in rats given scopolamine
28. Zur Pharmakologie von Ponalid, einem neuen zentralen Anticholinergicum
29. Neuroleptics and operant behaviour The anhedonia hypothesis
30. Predictability and specificity of behavioural screening tests for neuroleptics